Common use of Terms Defined Elsewhere Clause in Contracts

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Bylaws Capitalization Date Change of Recommendation Charter 3.2 5.2(a) 7.2(d) (i)(F) 3.1 Closing 2.1 Closing Date Company Company Approvals Company Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation Letter Continuation Period D&O Insurance Delisting Period Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Material Contract Material Customer Material Vendor Merger Merger Sub Non-Wholly Owned Subsidiary Notice of Redemption Notice Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.8

Terms Defined Elsewhere. As used in this Agreement, Each of the following capitalized terms are defined in this Agreement as referenced has the meaning ascribed to such term in the following tableArticle or Section set forth opposite such term: Acquired Company; Acquired Companies 3.3(b) Acquisition Proposal 6.6 Agreement Preamble Bylaws Capitalization Allocation Statement 7.3(i) Applicable Limitation Date Change of Recommendation Charter 3.2 5.2(a7.1 Basket 7.2(c) 7.2(dBusiness Relation 7.7(b) (i)(FBuyer Preamble Cap 7.2(c) 3.1 Closing 2.1 2.3 Closing Date 2.3 Closing Estimate Statement 2.2 Closing Items 2.4(a) Closing Statement 2.4(a) Company Preamble Company Approvals IP 3.11 Company Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation Letter Continuation Period D&O Insurance Delisting Period Employee Benefit Plan 3.16(a) Dispute Notice 2.4(b) Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Date Preamble Estimated Indebtedness 2.2 Estimated Foreign Withholding Amounts 2.2 Estimated Working Capital 2.2 Excess Amount 2.4(c) Financial Statements 3.4(a) Final Indebtedness 2.4(a) Final Foreign Withholding Amounts 2.4(a) Improvements 3.7 Indemnitee 7.2(g) Indemnitor 7.2(g) IRS 3.16(b) ▇▇▇▇▇ Preamble Latest Balance Sheet 3.4(a) Lease 3.7 Leased Real Property 3.7 Material Contract 3.10(b) Material Customer Customers 3.21 Material Vendor Merger Merger Sub Non-Wholly Owned Subsidiary Notice of Redemption Notice Notice Period Vendors 3.21 Monroe Preamble Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Parent Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Party Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) Pre-Closing Tax Period 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Straddle Period 7.3(c) Purchased Units Recitals Restricted Business 7.7(a) Restricted Period 7.7(a) Resolution Period 2.4(b) Sellers Preamble Seller Parties Preamble Subsidiaries 3.3(b) Shortfall Amount 2.4(c) Tax Representation Letters Third-Contest 7.3(d) Terminating Party Consents 6.8 Recitals 2.3 7.18(c8.1(b) 7.8▇▇▇▇ Preamble Units Recitals

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Anti-Corruption Laws 5.5(d) Bylaws Capitalization Date 3.2 Change of Recommendation 7.2(d)(i)(G) Charter 3.2 5.2(a) 7.2(d) (i)(F) 3.1 Closing 2.1 Closing Date 2.1 Company Preamble Company Approvals 5.4(a) Company Disclosure Letter Article V Company Personal Information 5.18(l) Company Recommendation Company Tax Representation Letter Continuation Period 5.3(b) D&O Insurance 7.12(a) Delisting Period 7.18(a) Effective Time 2.2 Exchange Fund FDA FDA Licenses Fundamental Action 4.3(a)(i) Excluded Share 4.1(b) Governmental Antitrust Entity 7.6(b)(ii) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(c) Material Contract 5.11(a)(xvi) Material Customer Payor 5.12(a) Material Vendor 5.12(b) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice of Redemption Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(b) Outside Date 9.2(a) Parent Preamble Parent Approvals Parent DSU 6.4(a) Parent Option 4.2(a)(ii) Parent RSU Parent Tax Representation Letter Parent SAR RSA 4.2(b) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Sale Transaction 7.6(d) Privacy and Security Measures Privacy-Related Contracts Requirements 5.18(k) Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Subsidiary Partnership 5.16(o) Surviving Corporation Tax Representation Letters 2.3 Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.87.8 Transaction Litigation 7.15

Terms Defined Elsewhere. As used The following terms are defined elsewhere in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following tableindicated below: Agreement Preamble Bylaws Capitalization Date Change of Recommendation Charter 3.2 Board Observer 5.3(b) Company Preamble Confidential Information 5.2(a) 7.2(dCorporate Opportunity Party 5.7 Demand 4.1(a) (i)(FDemand Registration 4.1(a) 3.1 Closing 2.1 Closing Date Company Company Approvals Company Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation Letter Continuation Drag Notice 3.7(b) Drag-Along Sale 3.7(a) Dragged Shareholders 3.7(a) Dragging Shareholders 3.7(a) Excess Shares 2.1(c) Executive Transfer 3.2(c) Family Member 3.2(b) Form S-3 Registration Statement 4.3(b) Form S-3 Shelf Registration Statement 4.3(b) Fully Participating Shareholder 2.1(c) Initial Exercise Period D&O Insurance Delisting 3.5(b) Initial Purchaser 2.1(g) Initiating Shelf Holder 4.4(a) IPO Holdback Period Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Material Contract Material Customer Material Vendor Merger Merger Sub Appendix Legend 6.1 Marketed Underwritten Shelf Take-Down 4.4(b) New Issuance 2.1(a) New Issuance Notice 2.1(a) Non-Wholly Owned Subsidiary Electing Shares 3.6(d) Non-Marketed Underwritten Shelf Take-Down 4.4(c) Non-Marketed Underwritten Shelf Take-Down Notice of Redemption 4.4(d) Notice Recipient 4.4(d) Offer Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential 3.5(a) Offer Price 3.5(a) Offered Securities 2.1(a) Offered Tag-Along Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.8Shares 3.6(b)

Terms Defined Elsewhere. As used in this Agreement. For purposes of this Agreement, the following capitalized terms are defined in this Agreement as referenced have the meanings set forth in the following tablesections indicated: Term Section Agreement Preamble Bylaws Capitalization Date Change of Recommendation Charter 3.2 5.2(aAssignment and Assumption 2.5(a)(v) 7.2(dBothell Property 2.10 Bothell ROFR Property 2.10 Bothell Safeway Property 2.10 Buyer Preamble Buyer Indemnified Parties 6.2(a) (i)(FCalifornia Real Property 8.3(a) 3.1 CAM Changes 2.6(a)(i) Claim Notice 6.3(a) Closing 2.1 2.4 Closing Date Company Company Approvals Company Disclosure Letter Company Personal Information Company Recommendation Company 2.4 Closing Sales Tax Representation Letter Continuation 2.8(c) Closing Sales Tax Forms 2.8(c) Closing Statement 2.5(a)(xiv) Code 2.11 Cost-to-Complete Budget True-up Amount 2.7(c) Cost-to-Complete Settlement Statement 2.7(a) Current Year Tax Appeal 2.6(a) Data Room 6.5(b) Deed 2.5(a)(i) Deposit Escrow Agreement 7.6 Development Plans 3.13 Disclosing Party 5.4(c) District LUEs 8.7(b) Draft ▇▇▇▇▇ ▇▇▇ Definition of ▇▇▇▇▇ ▇▇▇ ESPM 8.3(b) Exchanged Transferred Assets 5.11(a) Final Adjustment 2.7(c) Final Proration Period D&O Insurance Delisting Period Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Material 2.6(b) Final Proration Settlement Statement 2.6(b) Final Purchase Price 2.2 Guaranty Cap 7.10(a) Ground Lease Assignment 2.5(a)(i) Indemnified Party 6.3(a) Indemnifying Party Initial Deposit 6.3(a) 7.6 Initial Purchase Price 2.2 Leases 3.4(e) Licensed Website Content 5.2 LUEs 8.7(b) Minor Contract Material Customer Material Vendor Merger Merger Sub 3.6(b) Non-Wholly Owned Subsidiary Notice of Redemption Notice Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Party Affiliate 6.7(d) Occasional Sale Certificate 2.8(b) PDC Office Lease 2.5(a)(vii) Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(aContributor 6.4(f) Article V 5.18(lProrated Items 2.6(a) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) QI 5.11(a) 5.12(aRCW 8.9 Receiving Party 5.4(c) 5.12(bReferee Reference Commencement Notice Reference Stipulation 7.11 7.11 7.11 Released Claims 6.5(d) Recitals Required Estoppels 2.5(a)(xvi) Required Tenant Waivers 2.5(a)(xv) Safeway Marks 5.2 Sales Tax 2.8(c) Seller Preamble 5.2(fSeller Disclosure Statement 8.9 Seller Guaranteed Obligations 7.10(a) 7.13(aSeller Indemnified Parties 6.2(b) 7.2(d)(iiiSeller Marks 5.2 Seller Parent Preamble Seller Tenant Certificate 2.5(a)(xvii) 7.2(d)(iiiSurveys 2.9(a) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Claim 6.3(a) Title Commitment 2.9(a) Title Company 2.9(a) Title Notice 2.9(b) Transferred Assets Recitals 2.3 7.18(cTransition Services Agreement 2.5(a)(vi) 7.8True-up Accountant 2.6(b) True-up Amount True-up Covenant 2.6(b) 6.4(a) Unresolved Cost-to-Complete Items 2.7(c) Unresolved Items 2.6(b) Year-End 2.6(6)(i)

Terms Defined Elsewhere. As used In addition to the terms defined in this AgreementSection 1.1, each of the following capitalized terms are is defined in this the Section of the Agreement as referenced in the following tableset forth opposite such term below: Accounting Rules 5.6(b) ADSP 8.7(g) Allocation Schedule 8.7(g) Articles of Merger 2.2 Audited Buyer Financials 7.5(a) Audited Company Financials 5.6(a) Auditor 3.3(d)(i) Bank 5.1(a) Bank Merger 2.7 Bank Merger Agreement 2.7 Bankruptcy and Equity Exceptions 5.2 Basket 10.6(a)(i) BOLI 2.8(a)(ii)(C) Branch Leases 5.12(a)(i) Buyer Preamble Bylaws Capitalization Buyer Appraisal Delivery Date Change of Recommendation Charter 3.2 5.2(a3.4(a) 7.2(dBuyer Covered Losses 10.6(a)(i) (i)(FBuyer Disclosure Schedule Preamble to Article 7 Buyer Indemnitee 10.1 Buyer Losses 10.1 Buyer Plans 8.6(b) 3.1 Cap 10.6(a)(iii) Certificate 2.6(a) Claim Notice 10.3 Closed Branches 8.17 Closing 2.1 4.1 Closing Date 4.1 Closing Payment 3.1(a) Common Interest Information 8.22(c) Company Preamble Company Approvals Appraisal Delivery Date 3.4(c) Company Disclosure Letter Schedule Preamble to Article 5 Company Personal Information Financials 5.6(a) Company Recommendation Plans 5.18(a) Company Tax Representation Letter Continuation Period D&O Insurance Delisting Period Stock Recitals Damages 10.1 Derivative Transactions 5.13 Disclosure Schedule 8.11 Dispute Notice 3.3(b) Disputed Matters 3.3(b) Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity 2.2 Environmental Laws 5.17 Environmental Survey 8.21(a) ESOP 5.18(e) Estimated Effective Time Balance Sheet 3.2 FBCA Recitals FHLBA 5.1 Final Losses 10.4(e) Final Net Book Value 3.3(e) First Negotiation Period 3.4(b) Fiserv Contract 2.8(a)(ii)(H) Fraud 10.6(a) FRB 1.1(d) FTMC 5.1(a) FTST 5.1(a) Incumbent Counsel 8.14(a) Indemnified Party 10.3 Indemnifying Party 10.3 Interim Period Legal Restraint Company Financials 5.6(a) IRS 5.18(c) Lien 5.3 Losses 10.6(b) Material Contract Contracts 5.12(b) Material Customer Defect 8.21(d) Material Vendor Defect Notice 8.21(c) Merger Recitals Merger Sub Consideration 3.1(a) Monthly Financials 8.19 Negative True-Up Amount 3.3(e)(ii) Net Book Value 2.8(b) Non-Wholly Continuing Employee 8.6(a) Non-Performing 2.10(b) OCC 1.1(d) Order 5.8 Other Transferred Assets 2.9 Outside Closing Date 11.1(b)(ii) Owned Subsidiary Branch Property 5.16 Parent Preamble Parent Covered Losses 10.6(a)(ii) Parent Disclosure Schedule Preamble to Article 6 Parent Indemnitee 10.2 Parent Losses 10.2 Parties Preamble Permits 5.9 Permitted Real Estate Liens and Exceptions 5.16 Plaintiff Litigation 8.22(a) Policies 5.18 Pool 5.11(g) Positive True-Up Amount 3.3(e)(i) Property Examination 8.21(a) Property Review Appraisal Factors 8.21(c) Property Review Period 8.21(a) Put Date 8.16(c) Put Notice of Redemption Notice Notice 8.16(c) Put Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality 8.16(a) Qualified MAI Appraiser 3.4(a) Regulatory Approval 9.1(c) Representatives 8.3(a) Repurchase Price 8.16(g) Repurchased Loan 8.16(d) Response Period 10.4(a) Revised Effective Time Balance Sheet 3.3(a) Second Negotiation Period 3.4(d) Section 338(h)(10) Election 8.7(f) Servicing Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(iShares 2.6 Third Appraiser 3.4(e) 7.6(dThird Party Action 10.4(a) 7.6(dThird Party Action Notice 10.4(a) 5.18(kTransaction Documents 5.2 Transferred Assets 2.8(a)(ii) 5.11(a)(viTransferred Branch Lease 2.8(a)(ii)(D) 7.3(aTransferred Holding Company Assets 2.8(a)(i) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(cTransferred Loans 2.8(a)(ii)(B) 7.8Transferred Personal Property 2.8(a)(ii)(F) Transferred Owned Branch Property 2.8(a)(ii)(E) Transferred Employees 8.6(b) Transferred Loans 2.10(a) Transferred Records 8.4 Transitional Employees 8.6(a) TruPS 2.8(a)(i)(A) TruPS Assumption 8.15 USA PATRIOT Act 5.9

Terms Defined Elsewhere. As used In addition to the terms defined in this AgreementSection 1.1, each of the following capitalized terms are is defined in this Agreement as referenced in the following tableSection set forth opposite such term: Agreement Preamble Bylaws Capitalization Assumption Agreement 4.2(a)(ii) Assets 2.2 Assumed Contracts 2.2(b) Assumed Liabilities 2.4 Audits 5.6 ▇▇▇▇ of Sale 4.2(a)(i) Buyer Preamble Buyer Cap 8.6(b) Buyer Parties 8.1 Buyer Losses 8.1 Claim Notice 8.3 Claims Period 8.7 Closing 4.1 Confidential Information 7.4 Effective Date Change Preamble Excluded Assets 2.3 Excluded Contracts 2.5(c) Excluded Liabilities 2.5 Leased Real Property 5.10(b) Material Contracts 5.10(c) Offer of Recommendation Charter 3.2 5.2(aEmployment 7.2(a) 7.2(dOpen Source Materials 5.11(n) (i)(FParties Preamble Personal Property Leases 5.10(a) 3.1 Pre-Closing 2.1 Closing Date Company Company Receivables 2.2(g) Proposed Contract 4.3 Real Property Leases 5.10(b) Related Party 5.19(a) Response Period 8.4(a) Required Approvals Company Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation Letter Continuation Period D&O 4.3 Seller Preamble Seller Cap 8.6(a) Seller Insurance Delisting Period Effective Time Exchange Fund FDA FDA Licenses Fundamental Policies 5.12 Seller Parties 8.2 Seller Losses 8.2 Third Party Action Governmental Antitrust Entity Interim Period Legal Restraint Material Contract Material Customer Material Vendor Merger Merger Sub Non-Wholly Owned Subsidiary 8.4(a) Third Party Action Notice of Redemption Notice Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a8.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) Transferred Employee 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.8)

Terms Defined Elsewhere. As used In addition to the terms defined in this AgreementSection 1.1, each of the following capitalized terms are is defined in this Agreement as referenced in the following tableSection set forth opposite such term: Term Section Agreement Preamble Bylaws Capitalization Date Change Annual Financials 5.5(a) Assets 2.2 Assumed Contracts 2.2(b) Assumed Liabilities 2.4 Basket Amount 8.5(c) ▇▇▇▇ of Recommendation Charter 3.2 5.2(aSale 4.2(a)(i) 7.2(dBuyer Preamble Buyer Parties 8.1 Buyer Closing Certificate 4.2(b)(vii) (i)(FClaim Notice 8.3 Claims Period 8.5(a) 3.1 Closing 2.1 4.1 Closing Date Company Company Approvals Company Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation Letter Continuation 2.1 De Minimis Investment 5.16(a) Effective Date Preamble Employee Services Agreement 4.2(a)(ii) Excluded Assets 2.3 Excluded Contracts 2.5(c) Excluded Liabilities 2.5 Financial Statements 5.5(a) HSRL Loan 4.2(a)(x) Interim Balance Sheet 5.5(a) Term Section Interim Financials 5.5(a) License Agreements 5.10(a)(x) Lien Releases 4.2(a)(x) Material Contracts 5.10(a) Parent Preamble Parent Stockholder Claim 8.1(d) Parties Preamble Payoff Letters 4.2(a)(ix) Purchase Price 3.1 Related Party 5.16(a) Response Period D&O 8.4(a) Seller Preamble Seller Insurance Delisting Period Effective Time Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Material Contract Material Customer Material Vendor Merger Merger Sub Non-Wholly Owned Subsidiary Notice of Redemption Notice Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) Policies 5.12(a) 5.12(bSeller Parties 8.2 Seller Closing Certificate 4.2(a)(iv) Recitals Preamble 5.2(fThird Party Action 8.4(a) 7.13(aThird Party Action Notice 8.4(a) 7.2(d)(iiiTransferred IP 2.2(c) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.8Transferred Employees 7.2(a)

Terms Defined Elsewhere. As used The following terms are defined elsewhere in this Agreement, the following capitalized terms are defined in this as indicated below: Agent 3.2(a) Agent Agreement as referenced in the following table: 3.2(a) Agreement Preamble Bylaws Capitalization Date Change Antitrust Laws 8.2(b) Audited Driveline Financial Statements 8.12(a) Base Premium 8.4(d) Certificate 3.2(b)(ii) Certificate of Recommendation Charter 3.2 5.2(a) 7.2(d) (i)(F) 3.1 Merger 2.3 Closing 2.1 2.2 Closing Date Company Company Approvals Company 2.2 Covered Persons 8.4(a) ▇▇▇▇ Preamble ▇▇▇▇ Board Recitals ▇▇▇▇ Board Recommendation Recitals ▇▇▇▇ Common Stock 6.2(a) ▇▇▇▇ Disclosure Letter Company Personal Information Company Recommendation Company Tax Representation VI ▇▇▇▇ Equity Interests 6.2(a) ▇▇▇▇ Financial Statements 6.7(b) ▇▇▇▇ IP Agreements 6.16(b) ▇▇▇▇ Material Contract 6.14(b) ▇▇▇▇ Permits 6.17(b) ▇▇▇▇ Preferred Stock 6.2(a) ▇▇▇▇ SEC Documents 6.7(a) ▇▇▇▇ Transaction Litigation 8.8 Debt Commitment Letter Continuation Period D&O Insurance Delisting Period 6.24(a) Divestiture Action 8.2(c) Driveline Agreements 5.9(a) Driveline IP Agreements 5.11(b) Driveline Material Contract 5.9(b) Driveline Permit 5.12(b) Effective Time 2.3 Enforceability Exceptions 4.2(a) Exchange Fund FDA FDA Licenses Fundamental Action Governmental Antitrust Entity Interim Period Legal Restraint Material Contract Material Customer Material Vendor 3.2(a) Excluded Information 8.10(c)(iv) Fee Letter 6.23(a) Financing 6.23(a) GKN Preamble GKN Board Recitals GKN Board Recommendation Recitals GKN Disclosure Letter IV GKN Transaction Litigation 8.8 Indemnification Agreements 8.4(a) Merger 2.1 Merger Consideration 3.1(a)(i) Merger Regulation 9.1(d)(i) Merger Sub NonPreamble Merger Sub Common Stock 3.1(b) NYSE 4.4 Required Amount 6.23 ▇▇▇▇▇▇▇▇-Wholly Owned Subsidiary Notice of Redemption Notice Notice Period Outside Date Parent Parent Approvals Parent DSU Parent Option Parent RSU Parent Tax Representation Letter Parent SAR Parties Permitted Confidentiality Agreement Potential Purchasers Potential Sale Transaction Privacy and Security Measures Privacy-Related Contracts Proxy Statement 2.1 ▇▇▇▇▇ Act 6.7(a) SpinCo Preamble 5.4(aSpinCo Board 2.6(a)(i) Article V 5.18(lSpinCo Options 3.4(a) 5.3(bSpinCo PSUs 3.4(d) 7.18(cSpinCo RSUs 3.4(c) 7.11(aSpinCo SARs 3.4(b) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) 5.11(a)(vi) 7.3(a) -2- Stock Ownership Rep Support Agreement Surviving Corporation Tax Representation Letters Third-Party Consents 6.8 Recitals 2.3 7.18(c) 7.82.1 Transaction Litigation 8.8 Unaudited Interim Driveline Financial Statements 8.12(b)